| Antibody-dependent enhancement: a challenge for developing a safe dengue vaccine R Shukla, V Ramasamy, RK Shanmugam, R Ahuja, N Khanna Frontiers in cellular and infection microbiology 10, 572681, 2020 | 165 | 2020 |
| A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which … V Ramasamy, U Arora, R Shukla, A Poddar, RK Shanmugam, LJ White, ... PLoS neglected tropical diseases 12 (1), e0006191, 2018 | 80 | 2018 |
| Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement … R Shukla, RK Rajpoot, U Arora, A Poddar, S Swaminathan, N Khanna Frontiers in microbiology 8, 2644, 2018 | 33 | 2018 |
| Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed … A Poddar, V Ramasamy, R Shukla, RK Rajpoot, U Arora, SK Jain, ... BMC biotechnology 16, 1-10, 2016 | 29 | 2016 |
| Dengue envelope-based ‘four-in-one’ virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising … RK Rajpoot, R Shukla, U Arora, S Swaminathan, N Khanna Scientific Reports 8 (1), 8643, 2018 | 27 | 2018 |
| Recombinant dengue virus 4 envelope glycoprotein virus-like particles derived from Pichia pastoris are capable of eliciting homotypic domain III-directed neutralizing antibodies N Khetarpal, R Shukla, RK Rajpoot, A Poddar, M Pal, S Swaminathan, ... The American Journal of Tropical Medicine and Hygiene 96 (1), 126, 2017 | 27 | 2017 |
| Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models R Shukla, H Beesetti, JA Brown, R Ahuja, V Ramasamy, RK Shanmugam, ... EBioMedicine 60, 2020 | 24 | 2020 |
| Pichia pastoris-expressed Zika virus envelope domain III on a virus-like particle platform: design, production and immunological evaluation RK Shanmugam, V Ramasamy, R Shukla, U Arora, S Swaminathan, ... Pathogens and disease 77 (3), ftz026, 2019 | 23 | 2019 |
| Japanese Encephalitis Virus: an update on the potential antivirals and vaccines KS Srivastava, V Jeswani, N Pal, B Bohra, V Vishwakarma, AA Bapat, ... Vaccines 11 (4), 742, 2023 | 19 | 2023 |
| Cocculus hirsutus-Derived Phytopharmaceutical Drug Has Potent Anti-dengue Activity R Shukla, RK Rajpoot, A Poddar, R Ahuja, H Beesetti, RK Shanmugam, ... Frontiers in Microbiology 12, 746110, 2021 | 16 | 2021 |
| Zika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement R Shukla, RK Shanmugam, V Ramasamy, U Arora, G Batra, JA Acklin, ... EBioMedicine 54, 2020 | 13 | 2020 |
| Next generation designer virus-like particle vaccines for dengue R Shukla, V Ramasamy, RK Rajpoot, U Arora, A Poddar, R Ahuja, ... Expert review of vaccines 18 (2), 105-117, 2019 | 11 | 2019 |
| Sinococuline, a bioactive compound of Cocculus hirsutus has potent anti-dengue activity R Shukla, R Ahuja, H Beesetti, A Garg, C Aggarwal, S Chaturvedi, ... Scientific reports 13 (1), 1026, 2023 | 4 | 2023 |
| Cellular T-cell immune response profiling by tetravalent dengue subunit vaccine (DSV4) candidate in mice C Aggarwal, V Ramasamy, A Garg, R Shukla, N Khanna Frontiers in Immunology 14, 1128784, 2023 | 2 | 2023 |
| Cocculus hirsutus-derived phytopharmaceutical drug has potent anti-dengue activity A Poddar, R Shukla, H Beesetti, U Arora, RK Rajpoot, RK Shanmugam, ... bioRxiv, 2020.09. 18.303149, 2020 | 2 | 2020 |
| Japanese Encephalitis Virus: An Emerging Threat in the Indo-Pacific Region KS Srivastava, V Jeswani, N Pal, B Bohra, V Vishwakarma, AA Bapat, ... Preprints, 2022 | | 2022 |
| Zika virus subunit vaccine RK Shanmugham, V Ramasamy, R Shukla, U Arora, S Swaminathan, ... US Patent WO / 2020/208,434, 2020 | | 2020 |
| Use of cocculus hirsutus extract for treating dengue K Nayyar, U Arora, S Palla, M Prasad, S A, S Madan, R Sood, N Khanna, ... US Patent WO 2020/115723A1, 2020 | | 2020 |
| Tetravalent dengue vaccine and processes thereof RK Rajpoot, R Shukla, U Arora, N Khanna US Patent WO 2019/064312 A1, 2019 | | 2019 |
